Article

Module brings next-generation OCT technology

Heidelberg Engineering announces significant improvements to its Spectralis OCT2 Module.

Heidelberg Engineering announces significant improvements to its Spectralis OCT2 Module.  

The module brings next-generation optical coherence tomography (OCT) technology to the diagnostic imaging platform. It combines a high-scan rate with Heidelberg Engineering’s TruTrack Active Eye Tracking to provide unmatched image quality and significantly improved acquisition speed, according to the company

New applications, such as OCT angiography, will build on the module.

The module is an option for all new Spectralis models. In addition, a large number of devices in use-depending on their technical specifications-can be upgraded with the module.

Introduced with a high-scan rate of 70,000 Hz, Heidelberg Engineering was able to achieve another significant improvement in the acquisition speed, said the company in a prepared statement.

“[The] team in Heidelberg was able to increase the scan rate of the [module] from 70,000 Hz to 85,000 Hz,” said Kester Nahen, PhD, managing director at Heidelberg Engineering. “This is an important achievement and further substantiates the sound technology pathway we have defined. I’m confident that our customers will be delighted with this even more powerful engine.”

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.